China Pharma Holdings, Inc. – AMEX:CPHI

China Pharma Holdings stock price today

$1.415
+1.20
+574.13%
Financial Health
0
1
2
3
4
5
6
7
8
9

China Pharma Holdings stock price monthly change

-21.23%
month

China Pharma Holdings stock price quarterly change

-21.23%
quarter

China Pharma Holdings stock price yearly change

+77.97%
year

China Pharma Holdings key metrics

Market Cap
3.45M
Enterprise value
N/A
P/E
-0.43
EV/Sales
-0.16
EV/EBITDA
1.61
Price/Sales
0.01
Price/Book
0.03
PEG ratio
0.02
EPS
-0.32
Revenue
6.42M
EBITDA
-1.87M
Income
-3.55M
Revenue Q/Q
-30.12%
Revenue Y/Y
-24.10%
Profit margin
-52.03%
Oper. margin
-46.29%
Gross margin
-7.89%
EBIT margin
-46.29%
EBITDA margin
-29.2%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

China Pharma Holdings stock price history

China Pharma Holdings stock forecast

China Pharma Holdings financial statements

China Pharma Holdings, Inc. (AMEX:CPHI): Profit margin
Jun 2023 1.09M -593.02K -54.02%
Sep 2023 1.80M -777.6K -43.12%
Dec 2023 2.14M -1.23M -57.32%
Mar 2024 1.36M -955.89K -69.78%
China Pharma Holdings, Inc. (AMEX:CPHI): Debt to assets
Jun 2023 15704309 11.35M 72.28%
Sep 2023 15352357 9.24M 60.2%
Dec 2023 16469200 9.01M 54.74%
Mar 2024 16190449 7.89M 48.78%
China Pharma Holdings, Inc. (AMEX:CPHI): Cash Flow
Jun 2023 -216.43K 4.50K 934
Sep 2023 1.00M -67.45K -476.40K
Dec 2023 -22.32K -4.52K 30.37K
Mar 2024 -585.15K 0 6.85K

China Pharma Holdings alternative data

China Pharma Holdings, Inc. (AMEX:CPHI): Employee count
Aug 2023 234
Sep 2023 234
Oct 2023 234
Nov 2023 234
Dec 2023 234
Jan 2024 234
Feb 2024 234
Mar 2024 234
Apr 2024 234
May 2024 231
Jun 2024 231
Jul 2024 231

China Pharma Holdings other data

0.39% -1.67%
of CPHI is owned by hedge funds
170.51K -727.74K
shares is hold by hedge funds

China Pharma Holdings, Inc. (AMEX:CPHI): Insider trades (number of shares)
Period Buy Sel
Oct 2005 0 1828170
Transaction Date Insider Security Shares Price per share Total value Source
Option
WAUNG FRANK officer: Chief Financial Officer
Stock Option 40,000 N/A N/A
Option
WAUNG FRANK officer: Chief Financial Officer
Common Stock 4,052 N/A N/A
Sale
HALTER TIMOTHY P director, officer: CEO, Pres, C..
Common Stock, par value $0.001 per share 1,828,170 $0.1 $182,817
  • What's the price of China Pharma Holdings stock today?

    One share of China Pharma Holdings stock can currently be purchased for approximately $1.42.

  • When is China Pharma Holdings's next earnings date?

    Unfortunately, China Pharma Holdings's (CPHI) next earnings date is currently unknown.

  • Does China Pharma Holdings pay dividends?

    No, China Pharma Holdings does not pay dividends.

  • How much money does China Pharma Holdings make?

    China Pharma Holdings has a market capitalization of 3.45M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 13.48% to 7.01M US dollars.

  • What is China Pharma Holdings's stock symbol?

    China Pharma Holdings, Inc. is traded on the AMEX under the ticker symbol "CPHI".

  • What is China Pharma Holdings's primary industry?

    Company operates in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry.

  • How do i buy shares of China Pharma Holdings?

    Shares of China Pharma Holdings can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are China Pharma Holdings's key executives?

    China Pharma Holdings's management team includes the following people:

    • Ms. Zhilin Li Pres, Chief Executive Officer, Chairman & Interim Chief Financial Officer(age: 72, pay: $241,600)
  • How many employees does China Pharma Holdings have?

    As Jul 2024, China Pharma Holdings employs 231 workers, which is 1% less then previous quarter.

  • When China Pharma Holdings went public?

    China Pharma Holdings, Inc. is publicly traded company for more then 23 years since IPO on 17 Apr 2002.

  • What is China Pharma Holdings's official website?

    The official website for China Pharma Holdings is chinapharmaholdings.com.

  • How can i contact China Pharma Holdings?

    China Pharma Holdings can be reached via phone at +86 898 6681 1730.

China Pharma Holdings company profile:

China Pharma Holdings, Inc.

chinapharmaholdings.com
Exchange:

AMEX

Full time employees:

231

Industry:

Drug Manufacturers - Specialty & Generic

Sector:

Healthcare

China Pharma Holdings, Inc. develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products primarily to hospitals and private retailers in the People's Republic of China. The company offers products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. Its products include Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit; Gastrodin injection for tiredness, loss of concentration, poor sleep, and traumatic syndromes of the brain; Propylgallate and Ozagrel Sodium to treat cerebral thrombosis, coronary heart disease, and after surgery complications; Alginic Sodium Diester injection for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Bumetanide injection to treat edema diseases; and Candesartan for hypertension. It also provides Roxithromycin dispersible tablets for pharyngitis and tonsillitis; Cefaclor dispersible tablets for tympanitis, lower respiratory tract infection, urinary tract infections, and skin/skin tissue infection; Cefalexin capsules for acute tonsillitis; Andrographolide for sore throat caused by upper respiratory tract infection; Clarithromycin granules and capsules; and Naproxen Sodium and PseudophedrineHydrochlorida sustained release tablets. In addition, the company offers Hepatocyte growth-promoting factor, Tiopronin, Compound Ammonium Glycyrrhetate S, and Omeparzole for the treatment of digestive diseases. Further, it provides Vitamin B6 injection; Granisetron Hydrochloride injection to treat nausea and vomiting caused by radiotherapy and chemotherapy during the treatment of malignant tumors; Noni Enzyme, a food supplement; sanitizers; and masks. The company offers its products through distributors, as well as through its network of 16 sales offices and approximately 1,000 sales representatives. China Pharma Holdings, Inc. was founded in 1993 and is based in Haikou, the People's Republic of China.

No. 17, Jinpan Road
Haikou, 570216

CIK: 0001106644
ISIN: US16941T2033
CUSIP: 16941T104